Genome sequencing at Phoenix Children's Research Institute identifies interventions for cerebral palsy, showing 27% of 1,841 patients had identifiable genetic causes, with 25% of these actionable, potentially changing clinical management. Led by Dr. Michael Kruer, the study highlights genetic testing's role in precision treatments for CP.